Kinase Inhibitor News and Research

RSS
A protein kinase inhibitor is a type of enzyme inhibitor that specifically blocks the action of one or more protein kinases.
Inflection Biosciences' dual mechanism inhibitor shows promise as treatment for CLL

Inflection Biosciences' dual mechanism inhibitor shows promise as treatment for CLL

Researchers use x-ray crystallography to reveal how curcumin inhibits cancer

Researchers use x-ray crystallography to reveal how curcumin inhibits cancer

Ocular Therapeutix resubmits NDA for DEXTENZA

Ocular Therapeutix resubmits NDA for DEXTENZA

Coffee and the heart – four strong cups a day is beneficial finds study

Coffee and the heart – four strong cups a day is beneficial finds study

Experts propose new solutions to increase benefit, affordability of targeted cancer medicines

Experts propose new solutions to increase benefit, affordability of targeted cancer medicines

Researchers use innovative method to screen kinases for cancer drug's effectiveness

Researchers use innovative method to screen kinases for cancer drug's effectiveness

Scientists synthesize new multifunctional compound that has anti-tumor properties

Scientists synthesize new multifunctional compound that has anti-tumor properties

Leading medical societies update molecular testing guideline for lung cancer

Leading medical societies update molecular testing guideline for lung cancer

Novartis announces FDA approval of its first and only CML therapy with TFR data in product label

Novartis announces FDA approval of its first and only CML therapy with TFR data in product label

Overcoming Challenges of Assays of Complex Cellular Models with Real-Time Live-Cell Analysis

Overcoming Challenges of Assays of Complex Cellular Models with Real-Time Live-Cell Analysis

New targeted treatment could benefit patients with certain pancreatic tumors

New targeted treatment could benefit patients with certain pancreatic tumors

Osimertinib provides progression-free survival benefit to Asian patients with EGFR-mutated NSCLC

Osimertinib provides progression-free survival benefit to Asian patients with EGFR-mutated NSCLC

FDA approves first adjuvant treatment to reduce risk of kidney cancer recurrence

FDA approves first adjuvant treatment to reduce risk of kidney cancer recurrence

Study identifies promising treatment to reduce brain injury in babies

Study identifies promising treatment to reduce brain injury in babies

FDA grants approval to first treatment for rare blood cancer

FDA grants approval to first treatment for rare blood cancer

FDA approves new drug Zelboraf for Erdheim-Chester disease

FDA approves new drug Zelboraf for Erdheim-Chester disease

FDA grants accelerated approval to new treatment for mantle cell lymphoma

FDA grants accelerated approval to new treatment for mantle cell lymphoma

New approaches to treat aggressive NUT midline carcinoma

New approaches to treat aggressive NUT midline carcinoma

FDA grants accelerated approval to new drug for treating relapsed follicular lymphoma

FDA grants accelerated approval to new drug for treating relapsed follicular lymphoma

Scientists find new strategy for overcoming resistance to drugs in lung cancer patients

Scientists find new strategy for overcoming resistance to drugs in lung cancer patients